Cogent Biosciences annual operating margin
2017
2018
2019
2020
Cogent Biosciences's operating margin was −1,044.33% for fiscal 2020.
View full Cogent Biosciences company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −1,044.33% | −901.31 pp |
| 2019 | 2019-12-31 | −143.02% | +226.87 pp |
| 2018 | 2018-12-31 | −369.89% | −57.07 pp |
| 2017 | 2017-12-31 | −312.82% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2020 | 2020-09-30 | −18,333.01% | −17153.01 pp |
| Q2 2020 | 2020-06-30 | −1,402.08% | −1066.17 pp |
| Q1 2020 | 2020-03-31 | −87.34% | +300.51 pp |
| Q4 2019 | 2019-12-31 | 14.65% | +251.29 pp |
| Q3 2019 | 2019-09-30 | −1,180.00% | −662.33 pp |
| Q2 2019 | 2019-06-30 | −335.91% | +230.65 pp |
| Q1 2019 | 2019-03-31 | −387.85% | −73.16 pp |
| Q4 2018 | 2018-12-31 | −236.64% | +70.96 pp |
| Q3 2018 | 2018-09-30 | −517.67% | −227.48 pp |
| Q2 2018 | 2018-06-30 | −566.57% | — |
| Q1 2018 | 2018-03-31 | −314.68% | — |
| Q3 2017 | 2017-09-30 | −307.59% | — |
| Q2 2017 | 2017-06-30 | −290.19% | — |
Across the available reported history, Cogent Biosciences's operating margin decreased from −143.02% to −1,044.33%, a change of −901.31 percentage points. The latest reported quarter, Q3 2020, shows −18,333.01%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cogent Biosciences filings at SEC.gov ↗